(Total Views: 362)
Posted On: 12/09/2019 1:54:01 PM
Post# of 72436
![Avatar](https://investorshangout.com/images/ProfileImages/1873459762_62316_lemon.jpg)
Re: NotRichYet2 #61328
$2.5 billion for a phase 1 cancer drug. The difference being that their market cap was already around $1 billion.
A good, small phase 2a oral Kevetrin trial could translate into a billion dollar buyout very quickly.
A good, small phase 2a oral Kevetrin trial could translate into a billion dollar buyout very quickly.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)